In this episode of the Oncology Spotlight podcast, we are honored to host Prof. Keith Kerr, a Consultant Pathologist at Aberdeen Royal Infirmary and Honorary Professor at the University of Aberdeen. With over 35 years of experience in thoracic pathology, Prof. Kerr is a globally recognized expert in non-small cell lung cancer (NSCLC), particularly in predictive and diagnostic biomarkers, immunotherapy, and personalized medicine.

Join us as Prof. Kerr shares his remarkable journey from medical school to becoming a leading pathologist specializing in thoracic oncology. In this insightful conversation, he delves into:

• His Path to Pathology: Discover what led Prof. Kerr to specialize in thoracic oncology and how a pivotal research project in lung cancer set the course for his distinguished career.
  

• Understanding Reflex Testing in NSCLC: Prof. Kerr explains the concept of reflex testing, why it’s essential in the timely and accurate diagnosis of lung cancer, and how it has transformed patient care by ensuring that crucial molecular and biomarker tests are conducted without delay.
  

• The Impact of New Treatment Options: Learn how the advent of targeted therapies and immunotherapies for NSCLC has increased the importance of reflex testing and how it’s applied in current clinical practices.
  

• Challenges and Contributions to Lung Cancer Guidelines: Prof. Kerr shares his experiences and challenges in contributing to numerous national and international lung cancer guidelines, offering a unique perspective on the evolving standards in lung cancer diagnosis and treatment.
  

• Future of Pathology and the Role of AI: Prof. Kerr also discusses the future of pathology training, especially with the integration of new technologies and artificial intelligence in diagnostics, particularly for lung cancer.

Whether you're a healthcare professional, a student, or simply interested in the latest advancements in oncology, this episode offers valuable insights into the evolving field of lung cancer diagnosis and treatment.For inquiries, contact us at info@oncoassist.com

Let's connect:

Website: www.oncoassist.com

Twitter: https://twitter.com/oncoassist

LinkedIn: https://www.linkedin.com/showcase/oncoassist-oncology-decision-support-tool

Instagram:https://www.instagram.com/oncoassist/

Facebook: https://www.facebook.com/ONCOassist

Welcome to another episode of the Oncology Spotlight Podcast! In this episode, we're thrilled to have Eoin Tabb, Chief 2 Pharmacist specializing in Clinical Cancer Services at University Hospital Waterford, Ireland, as our guest. Eoin is a passionate advocate for digital health transformation, leading a team dedicated to enhancing the safety and efficiency of cancer care.

In this insightful conversation, Eoin shares his journey to becoming an oncology pharmacist, his specialization in cancer care, and how digital health is revolutionizing oncology today and in the future. We also dive into his work with The Irish Haematology Oncology Podcast, a jargon-free exploration of cancer care, designed to educate healthcare professionals and enthusiasts alike.

Key Discussion Points:

• Eoin’s background and journey to becoming a pharmacist

• Specializing in cancer care and the reasons behind it

• The impact of digital health transformation on cancer care today and its future potential

• The inspiration and goals behind The Irish Haematology Oncology Podcast

• Challenges faced by oncology professionals today

• How digital tools are helping to address these challenges

• The potential opportunities for AI in oncology

• Eoin’s aspirations for advancing cancer care through his current role and broader initiatives

Whether you’re a healthcare professional, digital health enthusiast, or simply interested in the future of cancer care, this episode offers valuable insights.

👉 Don’t forget to like, comment, and subscribe to our channel for more insightful episodes!🔔 Turn on notifications so you never miss an update.

🔗 Links:

• Listen to The Irish Haematology Oncology Podcast:

• Connect with Eoin Tabb on LinkedIn:

• For inquiries, contact us at info@oncoassist.com

Let's connect:

Website: www.oncoassist.com

Twitter: https://twitter.com/oncoassist

LinkedIn: https://www.linkedin.com/showcase/oncoassist-oncology-decision-support-tool

Instagram:https://www.instagram.com/oncoassist/

Facebook: https://www.facebook.com/ONCOassist

Welcome to the Oncology Spotlight! In this episode, join us as we delve into the forefront of cancer care with Professor Gerry Hanna, a distinguished radiation oncologist and Marie Curie Chair of Clinical Oncology at Trinity College Dublin.

Key Discussion Points:

Introduction: Get to know Professor Gerry Hanna and his illustrious career spanning leading institutions like Queen’s University Belfast and the University of Melbourne.

Latest Developments in Lung Cancer Treatment: Professor Hanna shares groundbreaking advancements shaping the future of lung cancer care.

Evolution of CRT in Lung Cancer: Discover insights into how Combined Radiation Therapy (CRT) has progressed over the past five years.

Interpreting Scans Post-CRT: Learn about challenges and strategies in interpreting scans, especially in conjunction with immunotherapy.

Emerging Guidelines for Scan Interpretation: Professor Hanna outlines emerging best practices crucial for accurate treatment decisions.

Role of Multidisciplinary Teams (MDT): Understand the pivotal role MDTs play in enhancing diagnostic accuracy and treatment planning.

Current Research Initiatives: Explore ongoing research projects like PERTAIN and CONCORDE and their potential impact on cancer care.

Challenges in Oncology Today: Professor Hanna discusses the significant challenges facing oncology and strategies to overcome them.

Future Prospects with AI: Gain insights into the promising intersection of oncology and artificial intelligence (AI).

Don't miss this enlightening conversation that promises to deepen your understanding of cutting-edge oncology practices and future directions in cancer treatment.

🎧 Listen to the full podcast episode: LINK and join the conversation!

🔬 Join us in this insightful conversation with Dr. Arturo Loaiza-Bonilla, Chief Medical Officer at MassiveBio, as he shares his journey and expertise in the ever-evolving landscape of oncology and artificial intelligence. 🚀

🌐 MassiveBio is at the forefront of transforming cancer care, leveraging AI to optimize workflows, enhance clinical trial matching, and revolutionize drug discovery. Dr. Loaiza-Bonilla delves into his experiences with ontology-based approaches, NLP, OCR, and the emergence of large AI models like GPT-3.

📈 Discover the potential of multi-modal approaches for prognostication in clinical trials and the groundbreaking use of AI in oncology research. Dr. Loaiza-Bonilla emphasizes the need for collaborative efforts to streamline processes, from patient recruitment to post-enrollment engagement.

🤖 As we explore the impact of AI in healthcare, Dr. Loaiza-Bonilla addresses the challenges in adoption, emphasizing the importance of regulatory clarity, incentives, and avoiding the fear of technology replacing human expertise.

👩‍⚕️ Dive into the heart of oncology challenges, where Dr. Loaiza-Bonilla sheds light on the fundamental need for improved biomarker testing. He advocates for patient-centric approaches, automated processes, and removing hurdles to ensure timely and accurate testing.

🌟 Exciting Advances in Cancer Treatment! Dr. Loaiza-Bonilla discusses recent breakthroughs, including bispecific antibodies, gene editing with CRISPR, and the promising developments in ADCs (antibody-drug conjugates). Learn how AI plays a pivotal role in accelerating drug efficacy assessments and in silico trials.

🎗️ Advice for Patients and Caregivers: Dr. Loaiza-Bonilla encourages individuals to be their own advocates, stressing the importance of asking questions, exploring biomarker-driven options, and planning for various treatment scenarios. Remember, your life is your journey, and collaboration with your healthcare team is key.

👨‍⚕️ Dr. Arturo Loaiza-Bonilla's insights are invaluable, providing a glimpse into the future of cancer care and the pivotal role AI plays in advancing treatments. Don't miss out on this engaging and informative conversation!

🔔 Subscribe for more updates on healthcare innovations, AI in medicine, and inspiring conversations with leading experts. Let's empower patients and caregivers on their cancer journey together!

#AIinOncology #CancerTreatment #HealthcareInnovations #MassiveBio #DrArturoLoaizaBonilla #AIRevolution

🌱 Explore the groundbreaking research on the intersection of food and immunotherapy in the latest episode of Oncology Spotlight. Join Dr. Sandrine Aspeslagh, a leading Medical Oncologist, as she shares insights into her work, from the early days of immunotherapy to innovative approaches in managing immune-related adverse events.

🎙️ In this episode, discover the FORX research program, which aims to reduce immune-related adverse events through high-fiber diets. Sandrine discusses the motivations behind this research, its potential impact on patient care, and the challenges faced in pioneering this approach. 

🌍 Support this transformative initiative by contributing to our crowdfunding campaign as we strive to empower patients through personalized dietary strategies. For Belgian citizens, your contribution is tax-deductible.

🔗 Crowdfunding Campaign: https://bit.ly/FORX_

📖 Don't miss this eye-opening conversation that goes beyond traditional cancer care.

🎙️ On today’s episode of Oncology Spotlight we’re stepping into the world of oncology care with Michelle Matthews and Anne-Marie Fay, the compassionate hosts behind the Answers for Cancers podcast. In this heartwarming interview, Michelle, deeply involved in cancer research, shares her journey to oncology, while Anne-Marie, transitioning from intensive care, offers a unique perspective gained from working with breast cancer patients.

👩‍⚕️ As they reflect on their nursing careers, these hosts open up about the profound personal connections that drew them to the field, influenced by family illnesses. Michelle's transition from teaching to nursing is explored, along with pivotal training experiences that shaped their paths, particularly encounters with oncology patients.

🌟 Sharing the joyous aspects of their work, Michelle and Anne-Marie emphasize the deep connections formed with patients, expressing gratitude for the meaningful friendships forged in the healthcare community. They delve into the origins of their podcast, The Answers for Cancers, revealing its evolution from a nurse-focused initiative to a platform centered on empowering patients.

🌍 The hosts discuss the global impact of their podcast, covering diverse topics such as lymphedema and psycho-oncology. Looking ahead, they express enthusiasm about the future of oncology, highlighting advancements in clinical trials. Michelle specifically shares her optimism regarding targeted therapies in breast cancer.
💡 In a warm message to patients and caregivers navigating the complexities of cancer care, Michelle and Anne-Marie offer valuable insights, underscoring the delicate balance needed when sharing information. Subscribe to their podcast for uplifting conversations and expert perspectives on cancer care: https://open.spotify.com/show/3BFSTkbPcbzHDKvWm2COYj?si=bdf37bec650a4b83

Welcome to "Oncology Spotlight"! In this episode, we shine light on blood cancer awareness, featuring an exclusive interview with Dr. Hisam Siddiqi, founder of Bread & Butter Hematology, a distinguished figure in the field of haematology. 

Join us as Dr. Siddiqi provides insights into his inspiring journey in medicine, delving into what sparked his passion for this field and why he chose to specialize in haematology. Discover the story behind the creation of "Bread & Butter Hematology," a unique initiative that has been making waves in the haematology community.

Learn about the vision and future plans for "Bread & Butter Hematology," and gain valuable insights into the future of haematology as Hisam Siddiqi shares his perspectives on the most groundbreaking developments and areas of focus in the upcoming decade.

Discover how patient-centered care and support form the cornerstone of Dr. Siddiqi's approach towards individuals dealing with haematology-related challenges. Gain a deeper understanding of the significant obstacles and challenges that haematology professionals face in current medical practice.

Stay tuned as Dr. Siddiqi graciously shares more about the fascinating world of haematology, offering a glimpse into upcoming projects that are set to make a difference. 🌟

🎙️ For more engaging discussions and expert insights, don't forget to subscribe to "Oncology Spotlight".